kaléo

Dec 12, 2018

Authorized Generic for EVZIO® (naloxone HCl injection) to be Available at a Reduced List Price of $178

Apr 26, 2018

With Life-Threatening Allergies Diagnosed in Infancy, kaléo Announces Availability of First and Only FDA-Approved Epinephrine Auto-Injector (EAI) for Infants and Toddlers Weighing 16.5 to 33 Pounds (7.5 to 15 kilograms)

Apr 18, 2018

NASCAR Driver Elliott Sadler Teams Up with kaléo about AUVI-Q® (Epinephrine Injection, USP) to Raise Awareness of Life-Threatening Allergies

Feb 21, 2018

Cabell-Huntington Health Department and the City of Huntington Fire Department Officials Named Co-Recipients of the 2017 kaléo Cares Award

Jan 11, 2018

More than 5000 Lives Reported Saved with Help of EVZIO® (naloxone HCl injection) Auto-injectors

Nov 20, 2017

U.S. FDA Approves Kaléo's AUVI-Q® (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children

Oct 24, 2017

Kaléo Along with National Advocacy Organizations Launch the "No Appetite for Bullying" Initiative

Aug 07, 2017

Kaléo Announces AUVI-Q® (epinephrine injection, USP) Charitable Donation Program for All Public Elementary Schools in the United States

Jul 27, 2017

U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaléo Specifically for Infants and Small Children